These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 14504499
1. Intraoperative injection of botulinum toxin A into the orbicularis oculi muscle for the treatment of crow's feet. Guerrissi JO. Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):161S-163S. PubMed ID: 14504499 [No Abstract] [Full Text] [Related]
2. Intraoperative injection of botulinum toxin A into orbicularis oculi muscle for the treatment of crow's feet. Guerrissi JO. Plast Reconstr Surg; 2000 May; 105(6):2219-25; discussion 2226-8. PubMed ID: 10839423 [Abstract] [Full Text] [Related]
3. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study. Prager W, Wissmüller E, Kollhorst B, Williams S, Zschocke I. Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046 [Abstract] [Full Text] [Related]
4. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin. Beer KR, Julius H, Dunn M, Wilson F. J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278 [Abstract] [Full Text] [Related]
7. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction. Sepehr A, Chauhan N, Alexander AJ, Adamson PA. Aesthetic Plast Surg; 2010 Oct; 34(5):583-6. PubMed ID: 20383497 [Abstract] [Full Text] [Related]
9. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study. Ascher B, Rzany BJ, Grover R. Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365 [Abstract] [Full Text] [Related]
11. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience. Farahvash MR, Arad S. J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691 [Abstract] [Full Text] [Related]
12. Cosmetic indications for botulinum A toxin. Foster JA, Wulc AE, Holck DE. Semin Ophthalmol; 1998 Sep; 13(3):142-8. PubMed ID: 9787215 [Abstract] [Full Text] [Related]
13. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. Lowe NJ, Lask G, Yamauchi P, Moore D. J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366 [Abstract] [Full Text] [Related]
14. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines. Lowe NJ, Shah A, Lowe PL, Patnaik R. J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785 [Abstract] [Full Text] [Related]
16. Oculoplastic experience with the cosmetic use of botulinum A exotoxin. Edelstein C, Shorr N, Jacobs J, Balch K, Goldberg R. Dermatol Surg; 1998 Nov; 24(11):1208-12. PubMed ID: 9834740 [Abstract] [Full Text] [Related]
17. Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study. Flynn TC, Carruthers JA, Carruthers JA, Clark RE. Dermatol Surg; 2003 Sep; 29(9):943-50; discussion 950-1. PubMed ID: 12930337 [Abstract] [Full Text] [Related]
18. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Zimbler MS, Holds JB, Kokoska MS, Glaser DA, Prendiville S, Hollenbeak CS, Thomas JR. Arch Facial Plast Surg; 2001 Sep; 3(3):165-9. PubMed ID: 11497500 [Abstract] [Full Text] [Related]
19. Sixth nerve palsy following botulinum toxin injection for facial rejuvenation. Dolar Bilge A, Sadigov F, Salar-Gomceli S. Cutan Ocul Toxicol; 2017 Jun; 36(2):193-194. PubMed ID: 27558865 [Abstract] [Full Text] [Related]
20. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics. Iozzo I, Tengattini V, Antonucci VA. J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277 [Abstract] [Full Text] [Related] Page: [Next] [New Search]